Sildenafil and Neuropathic Pain/Hemodynamics al. GABAB receptor modulation on the antinociception of intra- thecal sildenafil in the rat formalin test. Korean J Pain 2007;20: 106-110. 17. Wallis RM, Corbin JD, Francis SH, Ellis P. Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro. Am J Cardiol 1999;83:3C-12C. 18. Matsumoto T, Kobayashi T, Kamata K. Phosphodiesterases in the vascular system. J Smooth Muscle Res 2003;39:67-86. 19. Santos-Silva AJ, Cairr̃ao E, Morgado M, Alvarez E, Verde I. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries. Eur J Pharmacol 2008;582:102-9. 20. Kim SH, Chung JM. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992;50:355-63. 21. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quan- titative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994;53:55-63. 22. Blandizzi C, Bernardini MC, Natale G, Martinotti E, Del Tacca M. Peripheral 2-hydroxy-saclofen-sensitive GABA-B receptors mediate both vagal-dependent and vagal-independent acid secre- tory responses in rats. J Auton Pharmacol 1992;12:149-56. 23. Dogrul A, Ossipov MH, Lai J, Malan TP Jr, Porreca F. Peripheral and spinal antihyperalgesic activity of SIB-1757, a metabotropic glutamate receptor (mGLUR(5)) antagonist, in experimental neuropathic pain in rats. Neurosci Lett 2000;292:115-8. 24. Dworkin RH, O’Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007;132:237-51. 25. Dray A. Neuropathic pain: emerging treatments. Br J Anaesth 2008;101:48-58. 26. Torrance N, Smith BH, Bennett MI, Lee AJ. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain 2006;7:281-9. 27. Beavo JA, Reifsnyder DH. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci 1990;11:150-5. 28. Uckert S, Hedlund P, Andersson KE, Truss MC, Jonas U, Stief CG. Update on phosphodiesterase (PDE) isoenzymes as pharma- cologic targets in urology: present and future. Eur Urol 2006;50: 1194-207. 29. Freund TF, Buzsáki G. Alterations in excitatory and GABAergic inhibitory connections in hippocampal transplants. Neuroscience 1988;27:373-85. 30. Frotscher M, Léránth C, Lübbers K, Oertel WH. Commissural afferents innervate glutamate decarboxylase immunoreactive non-pyramidal neurons in the guinea pig hippocampus. Neurosci Lett 1984;46:137-43. 31. Grudt TJ, Jahr CE. Quisqualate activates N-methyl-D-aspartate receptor channels in hippocampal neurons maintained in culture. Mol Pharmacol 1990;37:477-81. 32. Li DP, Chen SR, Finnegan TF, Pan HL. Signalling pathway of nitric oxide in synaptic GABA release in the rat paraventricular nucleus. J Physiol 2004;554:100-10. 33. Yang Q, Chen SR, Li DP, Pan HL. Kv1.1/1.2 channels are down- stream effectors of nitric oxide on synaptic GABA release to preautonomic neurons in the paraventricular nucleus. Neuros- cience 2007;149:315-27. 34. Soares AC, Duarte ID. Dibutyryl-cyclic GMP induces perip-heral antinociception via activation of ATP-sensitive K(+) channels in the rat PGE2-induced hyperalgesic paw. Br J Pharmacol 2001; 134:127-31. 35. Zusman RM, Morales A, Glasser DB, Osterloh IH. Overall car- diovascular profile of sildenafil citrate. Am J Cardiol 1999;83: 35C-44C. 36. Jackson G, Benjamin N, Jackson N, Allen MJ. Effects of sildena- fil citrate on human hemodynamics. Am J Cardiol 1999;83:13C- 20C. 37. Ishikura F, Beppu S, Hamada T, Khandheria BK, Seward JB, Nehra A. Effects of sildenafil citrate (Viagra) combined with nitrate on the heart. Circulation 2000;102:2516-21. 38. Ravipati G, McClung JA, Aronow WS, Peterson SJ, Frishman WH. Type 5 phosphodiesterase inhibitors in the treatment of erectile dysfunction and cardiovascular disease. Cardiol Rev 2007;15:76-86. Yonsei Med J http://www.eymj.org Volume 51 Number 1 January 2010 87